Search
  • About Us
    • Company profile
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Pipeline overview
    • CDNF
    • Next generation xCDNF
    • Lymfactin
    • Scientific publications
  • Investors
    • Investors
    • Releases
    • Analyst Coverage
    • Financial Calendar
    • General Meetings
    • Financial Information
    • Share Information
    • Share Monitor
    • Investor Relations
    • Corporate Governance
  • News & Events
    • Herantis in the News
    • Events
    • Releases
    • Public materials
    • Video Presentations
    • Newsletter
  • Patients
    • Overview & Contact Us
    • Parkinson’s Disease
    • Lymphedema
    • Community Resources
  • Contact
  • FIN
Search

Latest releases

  • CDNF releases
  • Earnings Release
  • First north
  • General releases
  • Insider trading
  • Lymfactin releases
  • Newsletter
  • Press Release
  • Clear
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 02.06.2014
    FN
    Herantis Pharma successfully completes its initial public offering
  • 12.05.2014
    FN
    Herantis Pharma launches its initial public offering and applies for listing on First North
  • « Previous page
  • Page 1
  • ...
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Next page »

Quick links

Investors »
Releases »
Analyst Coverage »
Financial Calendar »
General Meetings »
Financial Information »
Share Information »
Share Monitor »
Investor Relations »
Corporate Governance »

HERANTIS PHARMA Plc
Bertel Jungin Aukio 1
FIN-02600 Espoo

Tel: +358 9 222 1195
Email: info (at) herantis.com
VAT number FI21986657

  • Legal notice
  • Privacy notice
  • Sign up for our bi-monthly newsletter

Copyright © HERANTIS PHARMA Plc. All rights reserved.

Cookies
This website uses cookies and Google Analytics. We use cookies and Google Analytics to adapt the website according to your preferences and to collect information about the use of the website. For more information regarding cookies we request you to review our privacy notice. The following terms and conditions are applied to the use of this website. By continuing to use this website you accept such terms and conditions.
OK
Privacy notice
Legal notice
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.